本司产品仅用于科研,不用于临床诊断和治疗

当前位置:首页 >> 技术支持 当前位置:首页 >> 技术支持 >> 文献应用

普诺赛致力于为科研客户提供高品质的细胞及培养相关产品,产品范围涵盖原代细胞、细胞系、胎牛血清,完全培养基,及其他培养试剂。经过多年的坚持和努力,普诺赛已协助客户发表高分文献4000余篇,文献常见于Nature Biotechnology、Nature Nanotechnology、Advanced Materials、Materials Today等行业顶尖期刊。

点击申请文献奖励

  • Landscape of pathogenic mutations in premature ovarian insufficiency (2023/02/02)
    IF: 82.900
    作者:Hanni Ke, Shuyan Tang, Ting Guo
    期刊: NATURE MEDICINE
    DOI:10.1038/s41591-022-02194-3
    引用产品: CL-0001   CL-0061   CL-0101  
  • Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo (2022/02/10)
    IF: 68.164
    作者:Yi Zongyi, Qu LiangTang, Huixian Liu
    期刊: Nature Biotechnology
    DOI:10.1038/s41587-021-01180-3
    引用产品: CL-0044  
  • Enantiomer-dependent immunological response to chiral nanoparticles (2022/01/19)
    IF: 64.800
    作者:Liguang Xu, Xiuxiu Wang ,Weiwei Wang
    期刊: Nature
    DOI:10.1038/s41586-021-04243-2
    引用产品: CP-H187B  
  • Programmable Magneto-Mechanoporation of Lysosomes Instructs Dynamic Macrophage Polarization for Antitumor Immunity (2023/05/09)
    IF: 64.500
    作者:Yingze Li, Mengge Zheng, Zhenyan Zhu
    期刊: CELL
    DOI:10.2139/ssrn.4441795
    引用产品: CL-0190  
  • Astragaloside IV derivative HHQ16 ameliorates infarction-induced hypertrophy and heart failure through degradation of lncRNA4012/9456 (2023/10/19)
    IF: 39.300
    作者:Jingjing Wan, Zhen Zhang, Chennan Wu
    期刊: Signal Transduction and Targeted Therapy
    DOI:10.1038/s41392-023-01660-9
    引用产品:
  • NPRC deletion mitigated atherosclerosis by inhibiting oxidative stress, inflammation and apoptosis in ApoE knockout mice (2023/08/09)
    IF: 39.300
    作者:Cheng Cheng, Jie Zhang, Xiaodong Li
    期刊: Signal Transduction and Targeted Therapy
    DOI:10.1038/s41392-023-01560-y
    引用产品: CL-0233  
  • APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients (2022/08/01)
    IF: 39.300
    作者:Hongsheng Zhang, Lin Shao, Zhihao Lin
    期刊: Signal Transduction and Targeted Therapy
    DOI:10.1038/s41392-022-01118-4
    引用产品: CL-0054  
  • Twist1-induced miR-199a-3p promotes liver fibrosis by suppressing caveolin-2 and activating TGF-β pathway (2020/06/05)
    IF: 39.300
    作者:Xiaoxue Yang, Liping Ma, Rong Wei
    期刊: Signal Transduction and Targeted Therapy
    DOI:10.1038/s41392-020-0169-z
    引用产品: CL-0560  
首页 上一页 12345 下一页 末页 合计1039页 合计8309条记录
×